BioSante Pharmaceuticals, Inc. (BPAX)

[jadite]

I have wondered about the Antares relationship for a while. The two companies are very quiet about any current relationship.

I rec'd this email from Donenberg and posted it at the time. Does this shed light on whether or not Antares is involved in the case of the sale of an unapproved product?

From January 2012
Q:I have a question about the new patent application filings: 20120004204 and 20120022033. In each case, is the gel suspension a formula patent owned by Antares Pharma?

A:The patent applications you site are broadly directed to using any transdermal testosterone formulation for decreasing CV risk, including existing formulations for male products, as well as formulations to which BioSante has rights, e.g., the Antares formulation.

There have been so many clinical trials some of which have allowed concommittant estrogen. Is it possible BPAX has collected the data for patients using both estrogen and testosterone and they are planning to sell a gel version of Estratest?

I have already voted for the merger but I am watching closely and would certainly consider changing my vote if this thing starts to smell any worse.